Identification of osteoglycin as a component of the vascular matrix: Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2437-2447

  Shanahan, Catherine M ^a,c   Cary, Nathaniel R B ^b   Osbourn, Jane K ^a   Weissberg, Peter L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Leucine rich repeat; Matrix; Osteoglycin; SM22

Indexed keywords

GLYCOPROTEIN; OSTEOGLYCIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL DIFFERENTIATION; CELL PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; RAT; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0031441716     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2437     Document Type: Article

References (16)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasamy M, Nagai R. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res. 1993;73:1000-1012.
3. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. Rat carotid neointimal smooth muscle cells re-express a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
4. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
5. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993;73:193-204.
6. Shanahan CM, Cary NRB, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994;93:2393-2402.
7. Madisen L, Neubauer M, Plowman G, Rosen D, Segarini P, Dasch J, Thompson A, Ziman J, Bentz H, Purchio AF. Molecular cloning of a novel bone-forming compound: osteoinductive factor. DNA Cell Biol. 1990;9:303-309.
8. Ujita M, Shinomura T, Kimata K. Molecular-cloning of the mouse osteoglycin-encoding gene. Gene. 1995; 158:237-240.
9. Smiley BL, Stuart K. Leucine-rich sequence in osteoinductive factor. J Bone Miner Res. 1990;5:1189-1190.
10. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991;64:867-869.
11. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature. 1990;346:281-284.
12. Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several non-connective tissue proteins in a variety of species. J Biol Client. 1989;264:4571-4576.
13. Bentz H, Nathan RM, Rosen DM, Armstrong RM, Thompson AY, Segarini PR, Mathews MC, Dasch JR, Piez KA, Seyedin SM. Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem. 1989;264:20805-20810.
14. Dasch JR, Pace DR, Avis PD, Bentz H, Chu S. Characterization of monoclonal antibodies recognizing bovine bone osteoglycin. Connect Tissue Res. 1993;30:11-21.
15. Hedin U, Bradford A, Bottger, Forsberg E, Johansson S, Thyberg S. Diverse effects of fibronectin and laminin on phenotypic prop-erties of cultured arterial smooth muscle cells. J Cell Biol. 1988;107: 307-309.
16. Yamamoto M, Uamamoto D, Noumura T. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype. Exp Cell Res. 1993;204:121-129.